Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
This study is currently recruiting participants.
Verified August 2012 by Stanford University
Sponsor:
Lawrence Recht
Collaborator:
Nektar Therapeutics
Information provided by (Responsible Party):
Lawrence Recht, Stanford University
ClinicalTrials.gov Identifier:
NCT01663012
First received: August 2, 2012
Last updated: August 8, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2015 |
| Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |